MMS
IndustrialsMaximus, Inc. · Specialty Business Services · $3B
What is Maximus, Inc.?
Maximus, Inc. is a mid-cap government services company headquartered in McLean, Virginia. It delivers business process services to health and human services programs across U.S. federal, state, local, and international government clients.
Maximus operates through three segments — U.S. Services, U.S. Federal Services, and Outside the U.S. — generating revenue by administering government health and human services programs on behalf of public-sector clients. The company handles program eligibility, enrollment support, appeals, assessments, and citizen engagement services. It also provides case management, document handling, and technology modernization work for federal agencies, making government programs more accessible to citizens.
Maximus was founded in 1997 and is headquartered in McLean, Virginia.
- Medicaid and CHIP program administration for state governments
- Federal citizen engagement centers and consumer education services
- Independent disability and health assessments
- Appeals processing for Medicare, Medicaid, and workers' compensation
- Government systems modernization and digital self-service solutions
Is MMS a Good Stock to Buy?
UQS Score rates MMS as Good overall, reflecting a balanced profile across its five analytical pillars.
The Quality pillar registers as Good, pointing to a business that generates consistent cash flows from long-term government contracts. The Valuation pillar is rated Attractive, suggesting the market may not be fully pricing in the company's earnings power relative to peers in the Industrials sector.
The Moat and Growth pillars both land at Neutral, indicating that competitive differentiation and near-term expansion opportunities are not standout features compared to higher-rated peers.
Pro members can view the complete pillar breakdown and underlying financial metrics to form a more complete picture of MMS. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does MMS pay dividends?
Yes — Maximus, Inc. pays a dividend.
Maximus pays a regular dividend, which is relatively uncommon among government services companies of its size. The dividend reflects the company's ability to generate steady cash flows from multi-year public-sector contracts. Income-oriented investors may find this cadence appealing, though the full yield context is available in the Pro member view.
When does MMS report earnings?
Maximus reports earnings on a quarterly cadence, consistent with standard practice for U.S.-listed equities.
Revenue trends at Maximus are shaped by government contract renewals, program expansions, and federal budget cycles. The company's exposure to Medicaid redeterminations and federal outsourcing demand has been a notable factor in recent reporting periods.
For the most recent quarter's results and guidance, visit Maximus's investor relations page directly.
MMS Price History
-21.2% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Maximus, Inc.?
Based on Maximus, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
MMS Long-term Outlook
The fundamental outlook for Maximus is shaped by its Neutral Growth and Neutral Risk pillar ratings, suggesting a steady rather than accelerating trajectory. Government outsourcing demand remains a structural tailwind, but contract concentration and budget-dependent revenue create a measured risk profile. The Attractive Valuation rating indicates potential upside if growth stabilizes or improves from current levels.
Growth drivers
- Ongoing government outsourcing of health and human services administration
- Federal agency modernization initiatives driving IT and BPS demand
- Expansion of Medicaid and public health program eligibility services
Key risks
- Revenue concentration in government contracts subject to budget cycles
- Competitive re-bidding pressure on large multi-year program contracts
- Regulatory or policy changes affecting Medicaid and federal program scope
MMS vs Peers
Maximus operates in a broad industrials and outsourced services landscape, where it competes with companies offering workforce, facility, and professional services to institutional clients.
Andersen focuses on professional and advisory services, contrasting with Maximus's deep specialization in government health program administration.
UniFirst delivers uniform and workwear services to businesses, representing a different outsourced services model compared to Maximus's public-sector BPS focus.
ABM provides facility and infrastructure services across commercial and government sites, whereas Maximus concentrates on citizen-facing program delivery.
Frequently Asked Questions
What does Maximus do?
Maximus provides business process services to government health and human services programs. It helps administer Medicaid, CHIP, federal marketplace eligibility, disability assessments, and citizen engagement services on behalf of U.S. state, federal, and international government clients.
Does MMS pay dividends?
Yes, Maximus pays a regular dividend. The company's stable government contract base supports consistent cash generation, which funds this dividend. For current yield and payout details, Pro members can access the full financial metrics view.
When does MMS report earnings?
Maximus reports on a quarterly cadence, as is standard for U.S.-listed companies. Specific upcoming report dates are not covered by our data source — check Maximus's investor relations page for the current schedule.
Is MMS a good stock to buy?
UQS Score rates MMS as Good overall. The Valuation pillar is Attractive and Quality is Good, while Moat and Growth are Neutral. Whether that profile fits your investment criteria depends on your goals — the full pillar breakdown is available to Pro members.
Is MMS overvalued?
The UQS Valuation pillar for MMS is rated Attractive, suggesting the stock may be reasonably priced relative to its earnings profile and sector peers. This does not constitute a price target or buy recommendation — see the full analysis for context.
How does MMS compare to its competitors?
Maximus is more narrowly focused on government health and human services outsourcing than peers like ABM Industries or UniFirst, which serve broader commercial markets. This specialization creates contract depth but also concentration risk. The UQS competitor comparison tool provides a side-by-side pillar view.
What is MMS's market cap bracket?
Maximus is classified as a mid-cap company. This places it in a range that typically offers more liquidity than small-caps while remaining more nimble than large-cap government services primes.
Who founded Maximus?
Maximus was founded in 1997. Founding details, including the names of original founders, are part of the company's publicly available corporate history — the Maximus investor relations and about pages are reliable sources for this information.
Is MMS a long-term quality stock?
As a long-term quality indicator, MMS earns a Good UQS Score. Its government contract base provides revenue stability, and the Attractive Valuation rating adds appeal. However, Neutral Moat and Growth ratings suggest investors should monitor competitive positioning and contract renewal trends over time.
What is the main competitive advantage of Maximus?
Maximus's primary advantage lies in its deep specialization in government health and human services administration. Long-term program contracts, regulatory expertise, and established relationships with state and federal agencies create meaningful switching costs for clients.
What sector does MMS belong to?
Maximus is classified in the Industrials sector. Within that broad category, it operates in the government outsourced services niche — a segment driven by public-sector budget decisions and program demand rather than traditional industrial cycles.
Unlock Full MMS Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View exact UQS pillar scores across all five dimensions
- ✓Access detailed financial metrics and trend data
- ✓Compare MMS side-by-side with sector peers
- ✓See the complete valuation and risk breakdown
- ✓Track score changes as new earnings data arrives
Pro Analysis
MMS — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| Apr 26, 2026 | 59.2 | 69.9 | 42.0 | 41.1 | 54.0 | 99.3 | 0.0 |
| Apr 19, 2026 | 59.2 | 69.9 | 42.0 | 41.1 | 54.0 | 99.0 | -0.2 |
| Apr 18, 2026 | 59.4 | 70.6 | 42.0 | 41.1 | 54.0 | 99.4 | -0.1 |
| Apr 11, 2026 | 59.5 | 70.6 | 42.0 | 41.1 | 54.0 | 100.0 | 0.0 |
| Apr 8, 2026 | 59.5 | 70.7 | 42.0 | 41.1 | 54.0 | 100.0 | -0.1 |
| Apr 7, 2026 | 59.6 | 71.0 | 42.0 | 41.1 | 54.0 | 100.0 | 0.0 |
| Apr 2, 2026 | 59.6 | 71.2 | 42.0 | 41.1 | 54.0 | 100.0 | — |
MMS — Pillar Breakdown
Quality
— 74.9/100 (25%)Maximus, Inc. shows solid profitability with healthy returns on capital and reasonable margins.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 37.6/100 (20%)Maximus, Inc. shows steady but unspectacular growth, typical for mature companies.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 54.8/100 (15%)Maximus, Inc. has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 100.0/100 (15%)Maximus, Inc. appears attractively valued relative to its earnings, cash flows, and sector peers.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 42/100 (25%)Maximus, Inc. possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for MMS.
Score Composition
Financial Data
More Stock Analysis
How is the MMS UQS Score Calculated?
The UQS (Unified Quality Score) for Maximus, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Maximus, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Maximus, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.